Good morning. Elizabeth Cooney here, about to relinquish the guest-host chair when Ed Silverman wraps up his tour of JPM in San Francisco. Lots of news there, lots of news everywhere. Here we go:

Verily, one of the most-talked-about debutants at this year’s J.P. Morgan ball, stumbled into apparent tension in its partnership with Dexcom (DXCM), STAT scoops. San Diego-based Dexcom launched in 2015 with the goal of creating a low-cost, disposable continuous glucose monitor for people with type 2 diabetes, the most common form of the disease that is tied to obesity and low activity levels. Verily, the Alphabet (GOOG) life sciences spinout, has embarked on a partnership with the diabetes device company to make a first-of-its-kind glucose monitor. But Verily CEO Andy Conrad said and showed more in a standing-room-only presentation than Dexcom CEO Kevin Sayer would have liked.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy